Today: 22. Dec, 2024
Half a decade ago, Moderna (MRNA) was a name that barely resonated in pharmaceutical circles. Focused on DNA-based drugs and vaccines, the company lingered on the periphery, largely overlooked by investors wary of speculative biotechnology ventures. Then came the seismic shock of…
Nathalie Palladitcheff, the CEO of Ivanhoe Cambridge, appeared on ‘Squawk on the Street’ to delve into the present conditions of the international real estate industry and the challenges faced by corporate real estate. In her conversation with the hosts, Palladitcheff analyzed how…
